I am hoping it was all strategic to keep the price lower while they argued for reduced licence fees, now that is all decided they will allow the share price to increase.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025